SLDB
Price
$4.03
Change
-$0.43 (-9.64%)
Updated
Dec 18, 04:59 PM (EDT)
TRDA
Price
$17.11
Change
-$1.34 (-7.26%)
Updated
Dec 18, 04:59 PM (EDT)
84 days until earnings call
Ad is loading...

SLDB vs TRDA

Header iconSLDB vs TRDA Comparison
Open Charts SLDB vs TRDABanner chart's image
Solid Biosciences
Price$4.03
Change-$0.43 (-9.64%)
Volume$748
CapitalizationN/A
Entrada Therapeutics
Price$17.11
Change-$1.34 (-7.26%)
Volume$4.08K
CapitalizationN/A
SLDB vs TRDA Comparison Chart
Loading...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLDB vs. TRDA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLDB is a Hold and TRDA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SLDB: $4.46 vs. TRDA: $18.45)
Brand notoriety: SLDB and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLDB: 129% vs. TRDA: 77%
Market capitalization -- SLDB: $178.2M vs. TRDA: $690.4M
SLDB [@Biotechnology] is valued at $178.2M. TRDA’s [@Biotechnology] market capitalization is $690.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLDB’s FA Score shows that 2 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • SLDB’s FA Score: 2 green, 3 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than SLDB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLDB’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • SLDB’s TA Score: 4 bullish, 4 bearish.
  • TRDA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than SLDB.

Price Growth

SLDB (@Biotechnology) experienced а -11.68% price change this week, while TRDA (@Biotechnology) price change was -10.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

SLDB is expected to report earnings on May 11, 2023.

TRDA is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($690M) has a higher market cap than SLDB($161M). TRDA YTD gains are higher at: 22.266 vs. SLDB (-27.362). TRDA has higher annual earnings (EBITDA): 61.3M vs. SLDB (-108.63M). TRDA has more cash in the bank: 449M vs. SLDB (171M). SLDB has less debt than TRDA: SLDB (24.7M) vs TRDA (61.3M). TRDA has higher revenues than SLDB: TRDA (215M) vs SLDB (0).
SLDBTRDASLDB / TRDA
Capitalization161M690M23%
EBITDA-108.63M61.3M-177%
Gain YTD-27.36222.266-123%
P/E RatioN/A11.88-
Revenue0215M-
Total Cash171M449M38%
Total Debt24.7M61.3M40%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLDBTRDA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLXGX25.47N/A
N/A
Virtus KAR Capital Growth I
FFCMX20.97-0.05
-0.24%
Fidelity Advisor Asset Manager 50% C
WXCIX13.61-0.04
-0.29%
William Blair Emerg Mkts ex China Gr I
BHCUX19.88-0.07
-0.35%
Baron Health Care R6
LAVVX15.61-0.09
-0.57%
Lord Abbett Fundamental Equity R6

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-3.04%
ACLX - SLDB
41%
Loosely correlated
-1.67%
TRDA - SLDB
40%
Loosely correlated
+2.44%
ABOS - SLDB
40%
Loosely correlated
-0.51%
ATHE - SLDB
38%
Loosely correlated
-1.73%
INZY - SLDB
38%
Loosely correlated
-2.65%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with PLRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+2.44%
PLRX - TRDA
47%
Loosely correlated
+4.74%
RXRX - TRDA
47%
Loosely correlated
-4.30%
PGEN - TRDA
46%
Loosely correlated
+2.46%
KYMR - TRDA
43%
Loosely correlated
-1.76%
RCKT - TRDA
43%
Loosely correlated
+1.36%
More